SCHEMBL5680754

SCHEMBL5680754

CC(C)Oc1cc(OCCN2CCN(C(=O)CN(C)C)CC2)cc2ncncc12.CC(C)Oc1cc(OCCN2CCNCC2)cc2ncnc(Nc3c(Cl)cnc4c3OCO4)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 20/20 0.54
KDR P35968 16/20 0.54
BMPR1B O00238 1/20 0.44
GAK O14976 1/20 0.44
EPHB6 O15197 1/20 0.44
RIPK2 O43353 1/20 0.44
STK10 O94804 1/20 0.44
MAP4K4 O95819 1/20 0.44
ABL1 P00519 1/20 0.44
EGFR P00533 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
YES1 P07947 1/20 0.44
LYN P07948 1/20 0.44
RET P07949 1/20 0.44
HCK P08631 1/20 0.44
PDGFRB P09619 1/20 0.44
FGR P09769 1/20 0.44
KIT P10721 1/20 0.44
BCR P11274 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3210348 0.93 SRC (0.61) SRCKDRBMPR1BGAKEPHB6
SCHEMBL3202589 0.87 SRC (0.68) SRCKDRBMPR1BGAKEPHB6
Azd-0424 SCHEMBL3202072 0.85 SRC (0.73) SRCKDRBMPR1BGAKEPHB6
Azd-0424 SCHEMBL29382167 0.85 SRC (0.73) SRCKDRBMPR1BGAKEPHB6
SCHEMBL3671966 0.82 SRC (0.68) SRCKDRBMPR1BGAKEPHB6
SCHEMBL3675514 0.82 SRC (0.70) SRCKDRBMPR1BGAKEPHB6
SCHEMBL3675255 0.81 SRC (0.74) SRCKDRBMPR1BGAKEPHB6
SCHEMBL3677564 0.80 SRC (0.73) SRCKDRBMPR1BGAKEPHB6
SCHEMBL6391139 0.80 SRC (0.48) SRCKDRPDGFRBKITFLT3
SCHEMBL3675427 0.80 SRC (0.81) SRCKDRBMPR1BGAKEPHB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620104-A1 THERAPEUTIC AGENTS COMPRISING AN ANTI-ANGIOGENIC AGENT IN COMBINATION WITH AN SRC-INHIBITOR AND THEIR THERAPEUTIC USE Astrazeneca AB (SE) 2006-02-01 EP disclosed
WO-2004098604-A1 THERAPEUTIC AGENTS COMPRISING AN ANTI-ANGIOGENIC AGENT IN COMBINATION WITH AN SRC-INHIBITOR AND THEIR THERAPEUTIC USE ASTRAZENECA AB (SE) 2004-11-18 WO disclosed